Cumberland Pharmaceuticals (CPIX) Net Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | -146.00 |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 1,518.00 |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | -3,607.00 |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | -610.00 |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -2,157.00 |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | -3,647.00 |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 166.00 |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 376.00 |
| 10 | Cumberland Pharmaceuticals | 96.11 Mn | 92.24 Mn | - | -237,480.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -237,480.00 |
| Mar 31, 2026 | -4,505.00 |
| Dec 31, 2025 | 787.00 |
| Sep 30, 2025 | -659.00 |
| Jun 30, 2025 | -18,187.00 |
| Mar 31, 2025 | 3,304.00 |
| Dec 31, 2024 | 4,916.00 |
| Sep 30, 2024 | -637.00 |
| Jun 30, 2024 | -1,911.00 |
| Mar 31, 2024 | -2,426.00 |
| Dec 31, 2023 | -4,042.00 |
| Sep 30, 2023 | -683.00 |
| Jun 30, 2023 | 2,117.00 |
| Mar 31, 2023 | 1,442.00 |
| Dec 31, 2022 | 1,973.00 |
| Sep 30, 2022 | 975.00 |
| Jun 30, 2022 | -2,676.00 |
| Mar 31, 2022 | -1,392.00 |
| Dec 31, 2021 | -3,777.00 |
| Sep 30, 2021 | -808.00 |